Suppr超能文献

在行为危险因素监测系统中调查电子烟吸烟者的前列腺特异性抗原筛查模式。

Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance system.

作者信息

Dagnino Filippo, Qian Zhiyu, Labban Muhieddine, Stelzl Daniel, Zurl Hanna, Korn Stephan, Beatrici Edoardo, Lughezzani Giovanni, Buffi Nicolò M, Lipsitz Stuart R, Kibel Adam S, Osman Nora, Trinh Quoc-Dien, Cole Alexander P

机构信息

Department of Urology Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Urology, Humanitas Research Hospital - IRCCS, Milan, Italy; Department of Biomedical Sciences, Humanitas University - Milan, Italy.

Department of Urology Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

出版信息

Urol Oncol. 2025 Apr;43(4):272.e1-272.e9. doi: 10.1016/j.urolonc.2024.09.036. Epub 2024 Oct 15.

Abstract

INTRODUCTION AND OBJECTIVES

E-cigarettes use has recently increased, even among older individuals quitting smoking. Though past studies suggest tobacco smokers may avoid cancer screening, the relationship between e-cigarette uses and preventive health behaviors like prostate specific antigen screening is uncertain. We assessed the relationship between self-reported e-cigarette smoking and prostate specific antigen screening utilization among US adults with a history of e-cigarette use.

MATERIALS AND METHODS

We included men aged 50-69 years, who provided responses regarding PSA screening receipt and smoking status, from Behavioral Risk Factor Surveillance System 2020 and 2022 surveys. Primary outcome was PSA screening receipt. Multivariable regression model was performed to investigate the association between smoking status (never-smokers, current or former e-cigarette smokers, current or former tobacco smokers) and PSA screening.

RESULTS

We included a weighted population of 8.1 million men aged 50-69. 2.3 million (28.3%) received PSA screening. 3.9 million (48.2%) were never-smokers. 1.3 million (16.6%) were from e-cigarettes smokers group, and 2.9 million (35.2%) were from tobacco smokers group. E-cigarettes smokers were less likely to receive PSA screening within last 2 years (0.76 [0.66-0.88]) than never-smokers. No significant difference in PSA screening was detected between never-smokers and tobacco smokers (0.91 [0.82-1.02]). E-cigarette smokers were less likely to receive PSA screening within the selected time frame (0.84 [0.72-0.97]) than tobacco smokers. When examining potential mediation by primary care visits, e-cigarette smokers were less likely to have had a check-up visit in past 2 years than tobacco smokers (0.77 [0.65-0.92]).

CONCLUSIONS

E-cigarette smokers were less likely to undergo PSA screening than never-smokers and tobacco smokers, possibly due to reduced use of primary care services.

摘要

引言与目的

电子烟的使用近来有所增加,甚至在戒烟的老年人中也是如此。尽管过去的研究表明吸烟者可能会避免癌症筛查,但电子烟使用与前列腺特异性抗原筛查等预防性健康行为之间的关系尚不确定。我们评估了有电子烟使用史的美国成年人中自我报告的电子烟吸烟与前列腺特异性抗原筛查利用率之间的关系。

材料与方法

我们纳入了年龄在50 - 69岁之间、在2020年和2022年行为危险因素监测系统调查中提供了前列腺特异性抗原筛查接受情况和吸烟状况的男性。主要结局是前列腺特异性抗原筛查接受情况。进行多变量回归模型以研究吸烟状况(从不吸烟者、当前或以前的电子烟吸烟者、当前或以前的烟草吸烟者)与前列腺特异性抗原筛查之间的关联。

结果

我们纳入了810万年龄在50 - 69岁之间的加权男性人群。230万(28.3%)接受了前列腺特异性抗原筛查。390万(48.2%)是从不吸烟者。130万(16.6%)来自电子烟吸烟者组,290万(35.2%)来自烟草吸烟者组。与从不吸烟者相比,电子烟吸烟者在过去2年内接受前列腺特异性抗原筛查的可能性较小(0.76 [0.66 - 0.88])。从不吸烟者和烟草吸烟者之间在前列腺特异性抗原筛查方面未检测到显著差异(0.91 [0.82 - 1.02])。与烟草吸烟者相比,电子烟吸烟者在选定时间范围内接受前列腺特异性抗原筛查的可能性较小(0.84 [0.72 - 0.97])。在检查初级保健就诊的潜在中介作用时,与烟草吸烟者相比,电子烟吸烟者在过去2年内进行体检就诊的可能性较小(0.77 [0.65 - 0.92])。

结论

与从不吸烟者和烟草吸烟者相比,电子烟吸烟者接受前列腺特异性抗原筛查的可能性较小,这可能是由于初级保健服务使用减少所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验